| Andrew Kelsey, MD | |
|
1078 W Main St, Waterbury, CT 06708-2651 | |
| (203) 757-1585 | |
| Not Available |
| Full Name | Andrew Kelsey |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 9 Years |
| Location | 1078 W Main St, Waterbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649664731 | NPI | - | NPPES |
| NN421 | Other | FL | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | ME148242 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Dermatology Of Vernon Pllc | 2961835798 | 4 |
| Integrated Dermatology Of Enfield, Llc | 6305061912 | 7 |
| Integrated Dermatology Of Clinton,llc | 7416257381 | 6 |
| Integrated Dermatology Of Groton Llc | 8527297050 | 4 |
| Integrated Dermatology Of Waterbury Llc | 9133467665 | 5 |
News Archive
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
1-800-DENTIST® has recently launched My Smile Bites, a nationwide $30,000 cosmetic dentistry makeover contest for anyone whose smile has impacted their lives negatively. As of today over 230 contestants have uploaded their personal two-minute videos, sharing their own stories about how their teeth affect the way they feel and interact with people.
It is widely accepted that higher levels of body fat increase the risk of developing breast cancer, as well as other cancers.
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
A team of researchers from Vanderbilt University's schools of Law, Medicine and Management has received a five-year research grant from the Agency for Healthcare Research and Quality of the Department of Health and Human Services to develop and test "safe harbor" standards of care based on scientific evidence.
› Verified 1 days ago
| Entity Name | Integrated Dermatology Of Groton Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265868558 PECOS PAC ID: 8527297050 Enrollment ID: O20140204000676 |
News Archive
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
1-800-DENTIST® has recently launched My Smile Bites, a nationwide $30,000 cosmetic dentistry makeover contest for anyone whose smile has impacted their lives negatively. As of today over 230 contestants have uploaded their personal two-minute videos, sharing their own stories about how their teeth affect the way they feel and interact with people.
It is widely accepted that higher levels of body fat increase the risk of developing breast cancer, as well as other cancers.
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
A team of researchers from Vanderbilt University's schools of Law, Medicine and Management has received a five-year research grant from the Agency for Healthcare Research and Quality of the Department of Health and Human Services to develop and test "safe harbor" standards of care based on scientific evidence.
› Verified 1 days ago
| Entity Name | Integrated Dermatology Of Enfield, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134544661 PECOS PAC ID: 6305061912 Enrollment ID: O20140715000874 |
News Archive
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
1-800-DENTIST® has recently launched My Smile Bites, a nationwide $30,000 cosmetic dentistry makeover contest for anyone whose smile has impacted their lives negatively. As of today over 230 contestants have uploaded their personal two-minute videos, sharing their own stories about how their teeth affect the way they feel and interact with people.
It is widely accepted that higher levels of body fat increase the risk of developing breast cancer, as well as other cancers.
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
A team of researchers from Vanderbilt University's schools of Law, Medicine and Management has received a five-year research grant from the Agency for Healthcare Research and Quality of the Department of Health and Human Services to develop and test "safe harbor" standards of care based on scientific evidence.
› Verified 1 days ago
| Entity Name | Integrated Dermatology Of Clinton,llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457728883 PECOS PAC ID: 7416257381 Enrollment ID: O20151125000408 |
News Archive
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
1-800-DENTIST® has recently launched My Smile Bites, a nationwide $30,000 cosmetic dentistry makeover contest for anyone whose smile has impacted their lives negatively. As of today over 230 contestants have uploaded their personal two-minute videos, sharing their own stories about how their teeth affect the way they feel and interact with people.
It is widely accepted that higher levels of body fat increase the risk of developing breast cancer, as well as other cancers.
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
A team of researchers from Vanderbilt University's schools of Law, Medicine and Management has received a five-year research grant from the Agency for Healthcare Research and Quality of the Department of Health and Human Services to develop and test "safe harbor" standards of care based on scientific evidence.
› Verified 1 days ago
| Entity Name | Integrated Dermatology Of Waterbury Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588136220 PECOS PAC ID: 9133467665 Enrollment ID: O20190208000034 |
News Archive
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
1-800-DENTIST® has recently launched My Smile Bites, a nationwide $30,000 cosmetic dentistry makeover contest for anyone whose smile has impacted their lives negatively. As of today over 230 contestants have uploaded their personal two-minute videos, sharing their own stories about how their teeth affect the way they feel and interact with people.
It is widely accepted that higher levels of body fat increase the risk of developing breast cancer, as well as other cancers.
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
A team of researchers from Vanderbilt University's schools of Law, Medicine and Management has received a five-year research grant from the Agency for Healthcare Research and Quality of the Department of Health and Human Services to develop and test "safe harbor" standards of care based on scientific evidence.
› Verified 1 days ago
| Entity Name | Integrated Dermatology Of Vernon Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063055853 PECOS PAC ID: 2961835798 Enrollment ID: O20191209000676 |
News Archive
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
1-800-DENTIST® has recently launched My Smile Bites, a nationwide $30,000 cosmetic dentistry makeover contest for anyone whose smile has impacted their lives negatively. As of today over 230 contestants have uploaded their personal two-minute videos, sharing their own stories about how their teeth affect the way they feel and interact with people.
It is widely accepted that higher levels of body fat increase the risk of developing breast cancer, as well as other cancers.
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
A team of researchers from Vanderbilt University's schools of Law, Medicine and Management has received a five-year research grant from the Agency for Healthcare Research and Quality of the Department of Health and Human Services to develop and test "safe harbor" standards of care based on scientific evidence.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Kelsey, MD 4700 Exchange Ct Ste 110, Boca Raton, FL 33431-4450 Ph: () - | Andrew Kelsey, MD 1078 W Main St, Waterbury, CT 06708-2651 Ph: (203) 757-1585 |
News Archive
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
1-800-DENTIST® has recently launched My Smile Bites, a nationwide $30,000 cosmetic dentistry makeover contest for anyone whose smile has impacted their lives negatively. As of today over 230 contestants have uploaded their personal two-minute videos, sharing their own stories about how their teeth affect the way they feel and interact with people.
It is widely accepted that higher levels of body fat increase the risk of developing breast cancer, as well as other cancers.
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
A team of researchers from Vanderbilt University's schools of Law, Medicine and Management has received a five-year research grant from the Agency for Healthcare Research and Quality of the Department of Health and Human Services to develop and test "safe harbor" standards of care based on scientific evidence.
› Verified 1 days ago
Dr. Jeffrey N Alter, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1078 W Main St, Waterbury, CT 06708 Phone: 203-757-1585 Fax: 203-757-0300 | |
Eugene Mirrer, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 171 Grandview Ave, Suite 103, Waterbury, CT 06708 Phone: 203-757-8919 Fax: 203-756-4697 | |
Salvatore V Romano, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 171 Grandview Ave, Suite 103, Waterbury, CT 06708 Phone: 203-757-8919 Fax: 203-756-4697 | |
Dr. Lance R Eriksen, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 171 Grandview Ave, Suite 103, Waterbury, CT 06708 Phone: 203-757-8919 Fax: 203-756-4697 |